Renaissance Technologies LLC boosted its position in Auna S.A. (NYSE:AUNA – Free Report) by 487.7% in the 1st quarter, HoldingsChannel reports. The firm owned 668,457 shares of the company’s stock after acquiring an additional 554,707 shares during the period. Renaissance Technologies LLC’s holdings in Auna were worth $3,683,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Goldman Sachs Group Inc. bought a new stake in Auna in the first quarter valued at approximately $219,000. Jane Street Group LLC acquired a new stake in shares of Auna in the fourth quarter valued at approximately $201,000. Squarepoint Ops LLC bought a new position in shares of Auna during the 4th quarter worth approximately $196,000. XTX Topco Ltd bought a new position in shares of Auna during the 4th quarter worth approximately $162,000. Finally, Millennium Management LLC increased its holdings in shares of Auna by 115.2% during the 4th quarter. Millennium Management LLC now owns 26,475 shares of the company’s stock worth $130,000 after acquiring an additional 14,170 shares during the last quarter.
Auna Stock Performance
Shares of NYSE AUNA opened at $5.32 on Friday. The company has a debt-to-equity ratio of 1.76, a current ratio of 1.09 and a quick ratio of 1.00. The firm has a market cap of $393.36 million, a price-to-earnings ratio of 20.44 and a beta of 0.61. The stock’s fifty day moving average price is $5.05 and its two-hundred day moving average price is $5.11. Auna S.A. has a one year low of $4.09 and a one year high of $6.85.
Insider Transactions at Auna
In other Auna news, President Leon Jesus Zamora purchased 30,000 shares of the stock in a transaction that occurred on Tuesday, May 26th. The shares were acquired at an average cost of $4.39 per share, with a total value of $131,700.00. Following the completion of the transaction, the president owned 45,914 shares in the company, valued at $201,562.46. The trade was a 188.51% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director John Wilton sold 17,574 shares of Auna stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $4.17, for a total transaction of $73,283.58. Following the completion of the sale, the director owned 49,974 shares of the company’s stock, valued at $208,391.58. This trade represents a 26.02% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders have purchased 83,454 shares of company stock worth $357,063.
Analyst Ratings Changes
A number of research firms recently weighed in on AUNA. Weiss Ratings restated a “sell (d)” rating on shares of Auna in a research note on Wednesday, June 24th. Wall Street Zen cut shares of Auna from a “strong-buy” rating to a “buy” rating in a research report on Sunday, July 5th. Finally, JPMorgan Chase & Co. decreased their price objective on shares of Auna from $6.00 to $5.00 and set a “neutral” rating on the stock in a report on Tuesday, May 26th. One investment analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $6.97.
Auna Company Profile
Auna, listed on the New York Stock Exchange under the ticker symbol AUNA, is a Peruvian integrated healthcare services company headquartered in Lima. The firm operates a diversified care network that spans hospitals, outpatient medical centers, diagnostic imaging and laboratory facilities, as well as optical and dental clinics. Auna’s organizational structure is designed to support a continuum of care model, offering both general and specialized treatments across multiple touchpoints.
The company delivers a broad range of clinical services, including emergency care, inpatient and outpatient surgery, obstetrics, cardiology, oncology, orthopedics, and other specialized disciplines.
See Also
- Five stocks we like better than Auna
- Datadog’s Drop Says More About Expectations Than Earnings
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
- Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
- Solventum Nears Inflection Point As It Begins to Unlock Value
Want to see what other hedge funds are holding AUNA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Auna S.A. (NYSE:AUNA – Free Report).
Receive News & Ratings for Auna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Auna and related companies with MarketBeat.com's FREE daily email newsletter.
